Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 34 | 2024 | 1571 | 4.790 |
Why?
|
Asthma | 38 | 2024 | 6139 | 3.270 |
Why?
|
Metabolome | 17 | 2024 | 949 | 2.350 |
Why?
|
Sphingolipids | 5 | 2023 | 170 | 1.180 |
Why?
|
Lymphoma, B-Cell | 4 | 2017 | 925 | 0.810 |
Why?
|
Vitamin D | 14 | 2024 | 3240 | 0.720 |
Why?
|
Lysine | 1 | 2024 | 986 | 0.660 |
Why?
|
Hypersensitivity, Immediate | 4 | 2023 | 342 | 0.650 |
Why?
|
Lymphoma, Follicular | 4 | 2015 | 446 | 0.650 |
Why?
|
Vitamins | 7 | 2024 | 1611 | 0.640 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2015 | 244 | 0.610 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2015 | 287 | 0.600 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2023 | 2440 | 0.590 |
Why?
|
Health | 1 | 2020 | 393 | 0.580 |
Why?
|
Cadmium | 2 | 2018 | 211 | 0.560 |
Why?
|
Vulnerable Populations | 1 | 2022 | 692 | 0.560 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2017 | 120 | 0.530 |
Why?
|
Lung | 5 | 2024 | 9918 | 0.510 |
Why?
|
Respiratory Sounds | 8 | 2024 | 688 | 0.490 |
Why?
|
Cholecalciferol | 1 | 2019 | 538 | 0.480 |
Why?
|
Carcinogens | 2 | 2018 | 448 | 0.440 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1380 | 0.420 |
Why?
|
Lead | 2 | 2018 | 855 | 0.410 |
Why?
|
Hypersensitivity | 4 | 2023 | 1138 | 0.410 |
Why?
|
Environmental Pollutants | 2 | 2023 | 1221 | 0.410 |
Why?
|
Costa Rica | 4 | 2019 | 174 | 0.380 |
Why?
|
Bacteremia | 1 | 2018 | 967 | 0.380 |
Why?
|
Pregnancy | 25 | 2024 | 29297 | 0.370 |
Why?
|
Immunoglobulin E | 4 | 2023 | 1496 | 0.350 |
Why?
|
Chromatography, Liquid | 5 | 2023 | 966 | 0.350 |
Why?
|
Interleukin-8 | 2 | 2022 | 689 | 0.340 |
Why?
|
Vital Capacity | 3 | 2021 | 953 | 0.340 |
Why?
|
Adrenal Cortex Hormones | 4 | 2023 | 1867 | 0.320 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1667 | 0.320 |
Why?
|
Humans | 101 | 2024 | 746630 | 0.320 |
Why?
|
Italy | 5 | 2019 | 824 | 0.320 |
Why?
|
Eczema | 2 | 2022 | 241 | 0.320 |
Why?
|
Food Hypersensitivity | 3 | 2022 | 687 | 0.310 |
Why?
|
Sweden | 5 | 2021 | 1368 | 0.310 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2019 | 1626 | 0.310 |
Why?
|
Vitamin D Deficiency | 3 | 2024 | 1356 | 0.300 |
Why?
|
Lipids | 4 | 2023 | 3290 | 0.290 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 507 | 0.280 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1379 | 0.280 |
Why?
|
Child | 27 | 2024 | 78492 | 0.280 |
Why?
|
Female | 61 | 2024 | 382450 | 0.270 |
Why?
|
Ejaculation | 2 | 2016 | 60 | 0.270 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2023 | 15386 | 0.270 |
Why?
|
Premature Birth | 3 | 2022 | 1725 | 0.260 |
Why?
|
Child, Preschool | 20 | 2024 | 41390 | 0.260 |
Why?
|
Forced Expiratory Volume | 2 | 2021 | 1789 | 0.260 |
Why?
|
Membrane Proteins | 3 | 2019 | 7786 | 0.250 |
Why?
|
Male | 51 | 2024 | 351420 | 0.250 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2176 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 10 | 2023 | 17445 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8356 | 0.240 |
Why?
|
Erythrocytes | 1 | 2013 | 2397 | 0.240 |
Why?
|
Case-Control Studies | 12 | 2020 | 21693 | 0.240 |
Why?
|
Macular Degeneration | 2 | 2024 | 996 | 0.230 |
Why?
|
Exercise | 1 | 2020 | 5688 | 0.230 |
Why?
|
Genome-Wide Association Study | 12 | 2023 | 12217 | 0.220 |
Why?
|
Air Pollution | 3 | 2021 | 2288 | 0.220 |
Why?
|
Prostatic Neoplasms | 5 | 2017 | 11215 | 0.220 |
Why?
|
Carnitine | 1 | 2024 | 251 | 0.220 |
Why?
|
Prospective Studies | 22 | 2023 | 53253 | 0.210 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1219 | 0.210 |
Why?
|
Genotype | 8 | 2023 | 12788 | 0.210 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3752 | 0.210 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2023 | 992 | 0.200 |
Why?
|
Environmental Exposure | 6 | 2021 | 4315 | 0.200 |
Why?
|
Inflammation | 4 | 2022 | 10633 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 134 | 0.190 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 193 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2022 | 261 | 0.180 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 579 | 0.170 |
Why?
|
Epidemiology | 2 | 2019 | 274 | 0.170 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1699 | 0.170 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 311 | 0.170 |
Why?
|
Academies and Institutes | 1 | 2022 | 312 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 365 | 0.170 |
Why?
|
Ethanolamines | 1 | 2019 | 156 | 0.170 |
Why?
|
Cohort Studies | 13 | 2024 | 40534 | 0.170 |
Why?
|
Dietary Supplements | 4 | 2024 | 3325 | 0.160 |
Why?
|
Multiple Myeloma | 2 | 2014 | 5096 | 0.160 |
Why?
|
Alleles | 3 | 2019 | 6837 | 0.160 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 666 | 0.160 |
Why?
|
Caffeine | 1 | 2022 | 684 | 0.160 |
Why?
|
Nitrogen Dioxide | 1 | 2021 | 494 | 0.150 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 256 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2019 | 423 | 0.150 |
Why?
|
Education | 1 | 2021 | 530 | 0.150 |
Why?
|
Depression, Postpartum | 1 | 2022 | 342 | 0.150 |
Why?
|
Eosinophils | 2 | 2023 | 939 | 0.150 |
Why?
|
Phenotype | 4 | 2023 | 16261 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 359 | 0.150 |
Why?
|
Fluorocarbons | 1 | 2023 | 467 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2021 | 662 | 0.150 |
Why?
|
Puerto Rico | 3 | 2024 | 362 | 0.150 |
Why?
|
Sphingosine | 1 | 2019 | 308 | 0.150 |
Why?
|
Infant | 11 | 2024 | 35456 | 0.140 |
Why?
|
Epidemiologic Methods | 2 | 2019 | 1337 | 0.140 |
Why?
|
RNA, Bacterial | 1 | 2019 | 382 | 0.140 |
Why?
|
Lysophospholipids | 1 | 2019 | 339 | 0.140 |
Why?
|
Candida albicans | 1 | 2020 | 373 | 0.140 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2028 | 0.140 |
Why?
|
Polychlorinated Biphenyls | 1 | 2019 | 234 | 0.140 |
Why?
|
Air Pollutants | 2 | 2021 | 2806 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 420 | 0.140 |
Why?
|
Body Burden | 1 | 2017 | 158 | 0.140 |
Why?
|
Phosphates | 1 | 2020 | 762 | 0.140 |
Why?
|
Computational Biology | 5 | 2021 | 3489 | 0.140 |
Why?
|
Middle Aged | 27 | 2024 | 214618 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 904 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1276 | 0.130 |
Why?
|
Fish Oils | 1 | 2019 | 473 | 0.130 |
Why?
|
Breath Tests | 1 | 2016 | 291 | 0.130 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 229 | 0.130 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 158 | 0.130 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 533 | 0.130 |
Why?
|
Receptors, Adiponectin | 1 | 2015 | 81 | 0.120 |
Why?
|
Anti-Asthmatic Agents | 1 | 2020 | 558 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2023 | 869 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 700 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 710 | 0.120 |
Why?
|
Reproducibility of Results | 2 | 2024 | 19819 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 737 | 0.120 |
Why?
|
Genetic Loci | 2 | 2014 | 2556 | 0.120 |
Why?
|
Adult | 24 | 2022 | 215192 | 0.120 |
Why?
|
Infant, Newborn | 7 | 2022 | 25759 | 0.110 |
Why?
|
Linear Models | 1 | 2024 | 5831 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1367 | 0.110 |
Why?
|
Leukemia, Lymphoid | 1 | 2013 | 308 | 0.110 |
Why?
|
Lung Diseases | 2 | 2021 | 1902 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2022 | 1140 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 179 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 242 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1598 | 0.110 |
Why?
|
DNA Methylation | 2 | 2019 | 4259 | 0.110 |
Why?
|
Receptors, IgE | 1 | 2014 | 381 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2015 | 378 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2022 | 1195 | 0.110 |
Why?
|
Body Mass Index | 4 | 2024 | 12657 | 0.110 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1876 | 0.100 |
Why?
|
Adolescent | 9 | 2022 | 86278 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.100 |
Why?
|
Risk Factors | 12 | 2023 | 72447 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 2014 | 442 | 0.100 |
Why?
|
Particulate Matter | 2 | 2021 | 2518 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1083 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1503 | 0.100 |
Why?
|
Neoplasms | 2 | 2018 | 21715 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 916 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1494 | 0.100 |
Why?
|
Aged | 21 | 2024 | 164383 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6068 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 2014 | 532 | 0.090 |
Why?
|
Infant, Premature | 1 | 2020 | 2042 | 0.090 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1416 | 0.090 |
Why?
|
Dietary Fats | 1 | 2018 | 1981 | 0.090 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 696 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7945 | 0.090 |
Why?
|
Tryptophan | 2 | 2024 | 478 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 905 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12280 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1229 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 1957 | 0.080 |
Why?
|
Gene Expression | 2 | 2020 | 7590 | 0.080 |
Why?
|
HLA Antigens | 1 | 2014 | 1340 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9599 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1431 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2133 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2595 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1393 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3748 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1408 | 0.080 |
Why?
|
Depression | 2 | 2024 | 7826 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 2 | 2023 | 1164 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 2 | 2024 | 782 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3670 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2679 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1966 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3025 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11865 | 0.060 |
Why?
|
Chromatin | 1 | 2017 | 2896 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3033 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3328 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15642 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3792 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1876 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9320 | 0.060 |
Why?
|
Young Adult | 9 | 2022 | 57163 | 0.060 |
Why?
|
Portugal | 1 | 2024 | 87 | 0.060 |
Why?
|
Temperature | 2 | 2021 | 2196 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3709 | 0.060 |
Why?
|
Feces | 2 | 2022 | 1432 | 0.060 |
Why?
|
Risk | 4 | 2019 | 9522 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3659 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2891 | 0.060 |
Why?
|
Ontario | 1 | 2024 | 391 | 0.050 |
Why?
|
Sphingomyelins | 1 | 2023 | 103 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2023 | 88 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10096 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5166 | 0.050 |
Why?
|
Fatty Acids | 2 | 2023 | 1777 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18157 | 0.050 |
Why?
|
Ceramides | 1 | 2023 | 202 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6782 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2023 | 102 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2022 | 12227 | 0.050 |
Why?
|
Software Design | 1 | 2022 | 172 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15312 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2013 | 3166 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5774 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2020 | 63732 | 0.050 |
Why?
|
Albuterol | 1 | 2021 | 209 | 0.050 |
Why?
|
Prognosis | 3 | 2016 | 29079 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2024 | 57586 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15319 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 96 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2021 | 325 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2024 | 38771 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 186 | 0.040 |
Why?
|
Milk, Human | 1 | 2022 | 474 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2020 | 242 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 742 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 886 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 235 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2019 | 171 | 0.040 |
Why?
|
Spirometry | 1 | 2021 | 904 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9193 | 0.040 |
Why?
|
Obesity | 2 | 2017 | 12728 | 0.040 |
Why?
|
Colorado | 1 | 2017 | 164 | 0.040 |
Why?
|
Problem Solving | 1 | 2020 | 437 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11966 | 0.040 |
Why?
|
Europe | 2 | 2014 | 3355 | 0.040 |
Why?
|
Bacteroides fragilis | 1 | 2018 | 235 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1702 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1028 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1028 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2018 | 457 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25184 | 0.030 |
Why?
|
Amines | 1 | 2017 | 278 | 0.030 |
Why?
|
Prostate-Specific Antigen | 2 | 2016 | 2511 | 0.030 |
Why?
|
Drug Discovery | 1 | 2023 | 1055 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2020 | 706 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1882 | 0.030 |
Why?
|
Allergens | 1 | 2022 | 1397 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2018 | 309 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2486 | 0.030 |
Why?
|
Kallikreins | 1 | 2016 | 232 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 243 | 0.030 |
Why?
|
DNA Replication | 1 | 2021 | 1378 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14124 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 552 | 0.030 |
Why?
|
Systems Biology | 1 | 2017 | 476 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Cesarean Section | 1 | 2022 | 1366 | 0.030 |
Why?
|
Meat Products | 1 | 2013 | 96 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 463 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 718 | 0.030 |
Why?
|
Family | 1 | 2024 | 3157 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 635 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 790 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2014 | 247 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2160 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 310 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 453 | 0.020 |
Why?
|
Nuts | 1 | 2013 | 262 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9213 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 984 | 0.020 |
Why?
|
Child Development | 1 | 2023 | 2251 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20763 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1758 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1137 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2013 | 716 | 0.020 |
Why?
|
Dairy Products | 1 | 2013 | 491 | 0.020 |
Why?
|
Social Environment | 1 | 2015 | 1009 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 876 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5764 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3039 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 20820 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 798 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1100 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2964 | 0.020 |
Why?
|
Prostate | 1 | 2017 | 1782 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1858 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1532 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 1963 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2722 | 0.020 |
Why?
|
Fruit | 1 | 2013 | 1150 | 0.020 |
Why?
|
Vegetables | 1 | 2013 | 1188 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2596 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3743 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 6939 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4617 | 0.020 |
Why?
|
Overweight | 1 | 2017 | 2389 | 0.020 |
Why?
|
Energy Intake | 1 | 2013 | 2123 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6454 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3790 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7685 | 0.020 |
Why?
|
Nutritional Status | 1 | 2013 | 1578 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2885 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2620 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6734 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4487 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2496 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2246 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9525 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13170 | 0.010 |
Why?
|
Mice | 2 | 2023 | 80251 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9513 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12021 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 13810 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4673 | 0.010 |
Why?
|
United States | 2 | 2021 | 70437 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7703 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10333 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12044 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8486 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15555 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10311 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9447 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4272 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 8983 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13317 | 0.010 |
Why?
|
Animals | 2 | 2023 | 166558 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39622 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23464 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13218 | 0.010 |
Why?
|